Loading clinical trials...
Loading clinical trials...
This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how common and if there are any risk factors for having calcinosis 2\) to identify common complications associa...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rutgers, The State University of New Jersey
NCT00024804 · Tumor Induced Osteomalcia, Osteomalacia, and more
NCT07470151 · System Lupus Erythematosus(SLE), Scleroderma, and more
NCT07228429 · Systemic Sclerosis (SSc), Calcinosis Cutis
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT06801119 · Systemic Lupus Erythematosus, Scleroderma, and more
RWJ Medical School
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions